Soleno Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	246.66	87.93	169.68	14.6	21.3	49.22
Short-Term Investments	252.27	203.51	-	-	-	-
Cash & Short-Term Investments	498.93	291.44	169.68	14.6	21.3	49.22
Cash Growth	94.31%	71.76%	1062.04%	-31.46%	-56.72%	137.42%
Receivables	25.51	-	-	-	-	-
Inventory	6.67	-	-	-	-	-
Prepaid Expenses	3.74	2.45	1.68	1.05	1.12	1.02
Total Current Assets	534.85	293.89	171.36	15.65	22.42	50.24
Property, Plant & Equipment	2.46	2.98	0.42	0.16	0.45	0.16
Long-Term Investments	57.15	27.21	-	-	-	-
Other Intangible Assets	5.35	6.81	8.75	10.69	12.64	14.58
Other Long-Term Assets	0.08	0.08	0.17	-	0.04	-
Total Assets	599.9	330.97	180.69	26.5	35.55	64.98
Accounts Payable	8.15	8.88	3.15	1.78	3.25	3.49
Accrued Expenses	24.3	6.6	6.53	4.9	4.15	4.79
Current Portion of Leases	0.7	0.53	0.27	0.16	0.28	0.15
Other Current Liabilities	0.11	2.74	1.56	0.48	0.32	0.19
Total Current Liabilities	33.25	18.75	11.51	7.31	8.01	8.62
Long-Term Debt	49.85	49.83	-	-	-	-
Long-Term Leases	2.11	2.47	0.13	-	0.18	-
Other Long-Term Liabilities	19.87	14.81	11.55	8.84	9.58	10.82
Total Liabilities	105.09	85.86	23.18	16.15	17.76	19.44
Common Stock	0.05	0.05	0.03	0.01	0.08	0.08
Additional Paid-In Capital	969.12	696.97	433.89	247.76	231.07	227.91
Retained Earnings	-474.73	-452.26	-276.41	-237.42	-213.36	-182.45
Comprehensive Income & Other	0.36	0.36	-	-	-	-
Total Common Equity	494.81	245.11	157.51	10.35	17.79	45.55
Shareholders' Equity	494.81	245.11	157.51	10.35	17.79	45.55
Total Liabilities & Equity	599.9	330.97	180.69	26.5	35.55	64.98
Total Debt	52.66	52.83	0.4	0.16	0.46	0.15
Net Cash (Debt)	503.42	265.82	169.28	14.45	20.85	49.08
Net Cash Growth	78.71%	57.03%	1071.72%	-30.70%	-57.52%	142.19%
Net Cash Per Share	10.38	6.62	10.26	1.72	3.92	11.76
Filing Date Shares Outstanding	53.71	45.86	32.46	8.17	5.34	5.31
Total Common Shares Outstanding	53.7	45.7	31.68	8.16	5.32	5.31
Working Capital	501.6	275.14	159.85	8.33	14.42	41.63
Book Value Per Share	9.21	5.36	4.97	1.27	3.34	8.58
Tangible Book Value	489.46	238.31	148.76	-0.35	5.16	30.97
Tangible Book Value Per Share	9.11	5.21	4.70	-0.04	0.97	5.83
Machinery	-	0.2	0.1	0.1	0.1	0.05
Leasehold Improvements	-	0.05	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.